Results 131 to 140 of about 4,104 (188)

Protective Effects of Pasireotide in LPS-Induced Acute Lung Injury. [PDF]

open access: yesPharmaceuticals (Basel)
Fakir S   +3 more
europepmc   +1 more source

Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years

open access: gold, 2016
Verena Theiler‐Schwetz   +9 more
openalex   +1 more source

[Hypoglycemia in a patient with pleural solitary fibrous tumor and response to pasireotide] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Videla EK   +6 more
europepmc   +1 more source

Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement

open access: green, 2020
Marie C. Hogan   +14 more
openalex   +2 more sources

Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma. [PDF]

open access: yesCell Mol Life Sci
G-García ME   +9 more
europepmc   +1 more source

Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model

open access: green, 2014
Katharina Hopp   +5 more
openalex   +2 more sources

SAT-LB076 T2-Signal Intensity, SST Receptor Expression and First-Generation Somatostatin Analogues Efficacy Predict Hormone and Tumor Responses to Pasireotide in Acromegaly

open access: gold, 2019
Eva C Coopmans   +7 more
openalex   +1 more source

Long-term Remission in Functioning Pituitary Adenomas after Medical Therapy Withdrawal: A Chance for Cushing's Disease. [PDF]

open access: yesEndocr Metab Immune Disord Drug Targets
Mondin A   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy